jeffreyssmartnews.publishlane.com

Can a GP Prescribe Medical Cannabis in the UK?

```html

The question of whether a GP (General Practitioner) can prescribe medical cannabis in the UK often sparks confusion—and for good reason. Despite changes to UK law in recent years making medical cannabis a legal treatment option under specific circumstances, widespread access remains tightly controlled and specialist-led. In this post, we’ll demystify the main points around medical cannabis UK prescriber rules, including the critical differences between Class and Schedule designations, the 2018 regulatory shift, and why NHS prescriptions are still rare. Along the way, we’ll also mention how services like Nationwide Pharmacies assist patients seeking legal access.

Class vs Schedule: A Crucial Legal Distinction

One of the biggest sources of confusion in discussions about medical cannabis in the UK relates to the terms “Class” and “Schedule.” These are legal categories with specific meanings, especially within drug law. Mixing them up can lead to incorrect assumptions about what is or isn’t permitted.

What Does "Class" Mean?

Class refers to the classification of a drug's harm and penalty level under the Misuse of Drugs Act 1971 (the 1971 Act). Cannabis is a Class B drug according to this Act, meaning possession and supply carry significant legal penalties.

Important note: Being Class B does not automatically mean a substance cannot be used medicinally under certain conditions—legal exemptions exist.

What Does "Schedule" Mean?

The Misuse of Drugs Regulations 2001 (often just called the Regulations) categorises controlled drugs into Schedules 1 through 5, determining how they can be prescribed and supplied within healthcare.

  • Schedule 1: Drugs with no recognised medicinal use and no legal prescribing (e.g., LSD, cannabis until 2018).
  • Schedule 2: High potential for abuse but recognised medical use (e.g., morphine, amphetamines).
  • Schedule 3, 4 & 5: Lower abuse potential; various controls on prescribing and supply.

Before November 2018, cannabis was a Schedule 1 drug, meaning prescription was essentially illegal even for medical purposes. This changed in late 2018.

Takeaway: Class refers to the severity of penalty under criminal law; Schedule refers to the legal prescribing framework in healthcare.

What Changed in November 2018?

In November 2018, the UK Government rescheduled cannabis-derived medicinal products (CDMPs) from Schedule 1 to Schedule 2 under the Misuse of Drugs Regulations. This was a watershed moment signalling that cannabis medicines could, in principle, be prescribed legally by doctors.

Two main things happened:

  1. Rescheduling of CDMPs to Schedule 2: This allowed doctors to prescribe these medicines under strict regulatory controls, similar to opioids or strong sedatives.
  2. Creation of Specialist-only Prescribing Pathway: To prevent inappropriate prescribing and ensure medical oversight, the General Medical Council (GMC) and NHS stipulated that only doctors on the GMC specialist register could initiate these prescriptions.

But what exactly does this specialist register requirement mean?

GMC Specialist Register Requirement Explained

Doctors in the UK are registered with the GMC, the medical regulator. They can be on the specialist register if they have completed recognised specialist training in fields such as neurology, oncology, or pain medicine.

For medical cannabis prescribing, this means:

  • Only specialists with relevant expertise can initiate a prescription for CDMPs.
  • GPs are generally unable to start new cannabis prescriptions, although they may continue prescribing if initiated by a specialist.

This specialist-only pathway is designed to ensure medical cannabis is prescribed only where clinically justified and with appropriate oversight.

Takeaway: Since 2018, medical cannabis prescriptions must be initiated by GMC-registered specialists, not by GPs starting new treatment.

Why Does Cannabis Remain Illegal Under the 1971 Act?

Even after rescheduling medicinal cannabis products to Schedule 2, the plant itself—whole cannabis flower or unlicensed preparations—remains illegal under the 1971 Act as a Class B drug. This legal framework prevents casual or unsupervised use, possession, or supply.

The reasoning includes:

  • Public safety concerns: Cannabis has psychoactive effects with potential for misuse.
  • Lack of standardised dosing: Unlicensed cannabis products vary widely in potency and composition.
  • International treaties: UK drug policy aligns with UN drug conventions classifying cannabis as a controlled substance.

Therefore, only licensed cannabis-based medicines—regulated, quality-assured pharmaceutical products—are legally prescribable under strict conditions.

Takeaway: The 1971 Act still criminalises cannabis plant possession and supply except for licensed medicines under controlled conditions.

GP vs Specialist Prescribing: What Are the Practical Differences?

Understanding the distinct roles of GPs and specialists helps clarify why medical cannabis access can feel so restricted.

Aspect GP Prescribing Specialist Prescribing Initiating Medical Cannabis Prescription Not allowed Allowed if on GMC specialist register with appropriate expertise Continuing Prescription Sometimes possible if specialist has initiated Yes Access via NHS Limited to continuing prescriptions, rare initial approvals Majority of approvals and prescribing decisions Private Prescribing Some private GPs may prescribe but still bound by GMC rules Specialists often provide private prescriptions

Because of these limits, many patients seeking medical cannabis prescriptions often turn to private specialist clinics or accredited companies like Nationwide Pharmacies, which help patients access legal cannabis-based products through compliant routes.

Takeaway: GPs generally cannot initiate new medical cannabis prescriptions; specialists on the GMC register handle prescribing decisions.

Why Is NHS Access to Medical Cannabis So Limited?

Despite the legal pathway created in 2018, NHS prescribing of medical cannabis remains “exceptional” rather than routine. Reasons include:

  • Lack of large-scale, high-quality clinical trial evidence to fully convince NHS clinical commissioning groups (CCGs) on cost-effectiveness and safety.
  • High cost of licensed cannabis medicines, making NHS funding challenging amid tight budgets.
  • Reluctance among some clinicians due to unfamiliarity or concerns about long-term effects and dependency risks.
  • Prescribing quotas and specialist service limitations, meaning only a handful of specialist centres currently have experience and capacity.

Consequently, most patients must seek private prescriptions or access cannabis products through limited NHS pathways—for example, children with rare epilepsy syndromes (like Dravet syndrome) may have more established routes.

Nationwide Pharmacies plays a key role here by supporting patients and clinicians in navigating private prescribing and sourcing quality cannabis medicines legally.

Takeaway: NHS prescribing of medical cannabis remains scarce due to evidence, cost, and service capacity constraints.

Summary: Medical Cannabis UK Prescriber Rules

  • Cannabis remains a Class B drug under the 1971 Act but licensed cannabis-based medicines are Schedule 2 drugs, legally prescribable under strict rules.
  • Since November 2018, only doctors on the GMC specialist register can initiate medical cannabis prescriptions.
  • GPs can sometimes continue prescriptions but cannot usually start new cannabis treatments.
  • NHS access is very limited; most prescriptions currently come from specialists or via private healthcare providers.
  • Companies like Nationwide Pharmacies provide guidance and legal dispensing support to patients pursuing medical cannabis treatment.

If you’re a patient considering medical cannabis in the UK, it’s essential to understand these rules to avoid illegal and unsafe sources. Always seek advice from authorised specialist consultants and licensed pharmacies.

Final takeaway: Medical tntmagazine.com cannabis prescribing in the UK is legal but tightly controlled—only specialists can start treatment, and NHS prescriptions remain rare.

```